News | Embolization devices | June 05, 2025

Penumbra Introduces Ruby XL System for Vascular Embolization

Penumbra's Ruby XL System for vascular embolization has received FDA clearance.

 

Penumbra Introduces Ruby XL System for Vascular Embolization

June 5, 2025 – Penumbra, Inc. has announced the U.S. Food and Drug Administration (FDA) clearance and launch of the Ruby XL System, the longest, largest and softest coil on the market[i]. The Ruby XL System is designed to help physicians achieve more efficient embolization, potentially reducing radiation exposure, and optimizing outcomes — especially in large vessel and high-flow embolization[ii].

"We’ve engineered Ruby XL to deliver more volume per coil than any other coil on the market, which may result in cost savings,” said Shruthi Narayan, President of Interventional Business at Penumbra, Inc. “Ruby XL embodies Penumbra’s commitment to innovation, delivering mechanical occlusion through more volume without sacrificing softness or deliverability.”

The Ruby XL System introduces three unique technologies — Ruby XL, POD® XL, and Packing Coil XL — all of which can be delivered through a 0.035”+ diagnostic catheter. They have a primary diameter of .030" and are designed for procedural efficiency. These coils offer more volume (up to 40mm in size) and are available in extended lengths up to 70 cm.

  • Engineered with a 3D complex shape, Ruby XL coil is designed to frame aneurysms in a variety of clinical applications.
  • POD XL features a hybrid, multistage design and is engineered with three-in-one coil occlusion technology — an anchoring segment, a framing segment, and a dense filling segment. Designed for high flow vessels, POD XL offers smooth delivery and targeted vessel control.
  • Packing Coil XL features an innovative liquid metal wave shape technology, which is designed to adjust dynamically to the size of any vessel (up to 70 cm length).

Penumbra’s Ruby portfolio of peripheral embolization products, now with Ruby XL System, provides physicians with one of the most expansive embolization offerings, enabling physicians to have the latest coil technologies and most extensive options for every case. For more information, please visit www.penumbrainc.com/products/ruby-xl.

 

[i] Data as of May 2025, Ruby XL System is the largest and longest detachable embolization coil commercially available and the only 035 packing coil commercially available.

[ii] Ruby XL is 2X larger than Ruby 020 coils and 3X larger than conventional 035 coils. Fewer coils used may potentially lead to reduced radiation exposure.

 


Related Content

News | Embolization devices

July 28, 2022 — Instylla, Inc., a privately held company developing next-generation liquid embolics for peripheral ...

Home July 28, 2022
Home
News | Embolization devices
March 31, 2022 – Instylla, Inc., a privately held company developing next-generation liquid embolics for peripheral ...
Home March 31, 2022
Home
News | Embolization devices

March 29, 2022 – Artio Medical, Inc., a medical device company developing innovative products for the peripheral ...

Home March 29, 2022
Home
News | Embolization devices

October 16, 2017 — Medtronic announced the launch of the Concerto 3-D Detachable Coil System at the Cardiovascular and ...

Home October 16, 2017
Home
News | Embolization devices

February 24, 2016 — ArtVentive Medical Group Inc. announced enrollment in the ongoing ArtVentive EOS Endoluminal ...

Home February 24, 2016
Home
Technology | Embolization devices

January 14, 2016 — Penumbra Inc. announced the U.S. launch of its new POD Packing Coil, designed as a complementary ...

Home January 14, 2016
Home
News | Embolization devices

December 17, 2015 — ArtVentive Medical Group conducted its first animal study of its next generation of the ArtVentive ...

Home December 17, 2015
Home
Technology | Embolization devices

August 17, 2015 — Merit Medical Systems Inc. announced that it has received 510(k) clearance from the U.S. Food and Drug ...

Home August 17, 2015
Home
Subscribe Now